Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Accumulated Expenses (2016 - 2024)

Cellectis (CLLS) has 3 years of Accumulated Expenses data on record, last reported at $7.0 million in Q4 2018.

  • For Q4 2018, Accumulated Expenses rose 17.7% year-over-year to $7.0 million; the TTM value through Dec 2018 reached $7.0 million, up 17.7%, while the annual FY2018 figure was $7.0 million, 17.7% up from the prior year.
  • Accumulated Expenses reached $7.0 million in Q4 2018 per CLLS's latest filing, up from $6.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $7.0 million in Q4 2018 and bottomed at $4.1 million in Q4 2016.
  • Average Accumulated Expenses over 3 years is $5.7 million, with a median of $6.0 million recorded in 2017.
  • Peak YoY movement for Accumulated Expenses: skyrocketed 44.49% in 2017, then rose 17.7% in 2018.
  • A 3-year view of Accumulated Expenses shows it stood at $4.1 million in 2016, then surged by 44.49% to $6.0 million in 2017, then increased by 17.7% to $7.0 million in 2018.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $7.0 million in Q4 2018, $6.0 million in Q4 2017, and $4.1 million in Q4 2016.